Older patients with mantle cell lymphoma (MCL): Practice patterns and predictors of survival in the rituximab era.

被引：0

作者：

Karmali, Reem

Switchenko, Jeffrey M.

Goyal, Subir

Bachanova, Veronika

Gerson, James

Barta, Stefan K.

Danilov, Alexey Valeryevich

Grover, Natalie Sophia

Epperla, Narendranath

Burkart, Madelyn

Sawalha, Yazeed

Ghosh, Nilanjan

Bond, David Alan

Maddocks, Kami J.

Badar, Talha

Fenske, Timothy

Guo, Jin

Malecek, Mary-Kate

Martin, Peter

Cohen, Jonathon Brett

机构：

[1] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA

[2] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA

[3] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA

[4] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[5] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA

[6] Univ Minnesota, Minneapolis, MN USA

[7] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[8] Univ Penn, Philadelphia, PA 19104 USA

[9] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA

[10] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA

[11] Ohio State Univ, Columbus, OH 43210 USA

[12] Northwestern Mem Hosp, Chicago, IL 60611 USA

[13] Cleveland Clin, Cleveland, OH 44106 USA

[14] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA

[15] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA

[16] Ohio State Univ, Dept Internal Med, Div Hematol, Comprehens Canc Ctr, Columbus, OH 43210 USA

[17] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[18] Weill Cornell Med Coll, New York, NY USA

[19] Washington Univ, St Louis, MO 63110 USA

[20] New York Presbyterian Hosp, Weill Cornell Med, New York, NY USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期

基金：

美国国家卫生研究院;

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e20064

引用

页数：2

共 50 条

[31] Treatment patterns and outcomes of older patients with mantle cell lymphoma in an Asian population
Xinyi Yang
Lay Poh Khoo
Esther Wei Yin Chang
Valerie Shiwen Yang
Eileen Poon
Nagavalli Somasundaram
Mohamad Farid
Tiffany Pooi Ling Tang
Miriam Tao
Soon Thye Lim
Jason Yongsheng Chan
BMC Cancer, 21
[32] Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse
Kumar, Anita
Sha, Fushen
Toure, Ahmed
Dogan, Ahmet
Ni, Andy
Batlevi, Connie L.
Palomba, Maria Lia M.
Portlock, Carol
Straus, David J.
Noy, Ariela
Horwitz, Steven M.
Moskowitz, Alison
Hamlin, Paul
Moskowitz, Craig H.
Matasar, Matthew J.
Zelenetz, Andrew D.
Younes, Anas
BLOOD CANCER JOURNAL, 2019, 9 (6)
[33] Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse
Anita Kumar
Fushen Sha
Ahmed Toure
Ahmet Dogan
Andy Ni
Connie L. Batlevi
Maria Lia M. Palomba
Carol Portlock
David J. Straus
Ariela Noy
Steven M. Horwitz
Alison Moskowitz
Paul Hamlin
Craig H. Moskowitz
Matthew J. Matasar
Andrew D. Zelenetz
Anas Younes
Blood Cancer Journal, 9
[34] Real-World Practice Patterns and Outcomes Following Bruton Tyrosine Kinase Inhibitors (BTKi) in Older Patients with Mantle Cell Lymphoma (MCL): A Population-Based Analysis
Di, Mengyang
Long, Jessica B.
Kothari, Shalin K.
Sethi, Tarsheen
Zeidan, Amer M.
Podoltsev, Nikolai A.
Shallis, Rory Michael
Wang, Rong
Stempel, Jessica M.
Ma, Xiaomei
Huntington, Scott F.
BLOOD, 2022, 140 : 10904 - 10906
[35] Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in Japan
Chihara, Dai
Asano, Naoko
Ohmachi, Ken
Kinoshita, Tomohiro
Okamoto, Masataka
Maeda, Yoshinobu
Mizuno, Ishikazu
Matsue, Kosei
Uchida, Toshiki
Nagai, Hirokazu
Nishikori, Momoko
Nakamura, Shigeo
Ogura, Michinori
Suzuki, Ritsuro
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (05) : 657 - 668
[36] Clinical Validation of MCL35 in Mantle Cell Lymphoma Patients ≥65 Years Receiving Bendamustine-Rituximab
Rosenthal, Allison C.
Ramsower, Colleen
Mwangi, Raphael
Maurer, Matthew J.
Villa, Diego
McDonnell, Timothy J.
Feldman, Andrew L.
Habermann, Thomas M.
Cohen, Jonathon B.
Robetorye, Ryan S.
Campo, Elias
Gine, Eva
Cook, James R.
Hill, Brian T.
Raess, Philipp
Ott, German
Reichart, Alexander
Scott, David W.
Rimsza, Lisa M.
BLOOD, 2021, 138
[37] Safety and Efficacy of Acalabrutinib Plus Venetoclax and Rituximab in Patients with Treatment-Naive (TN) Mantle Cell Lymphoma (MCL)
Wang, Michael
Robak, Tadeusz
Maddocks, Kami J.
Phillips, Tycel
Smith, Stephen D.
Gallinson, David
Calvo, Roser
Wun, Chuan-Chuan
Munugalavadla, Veerendra
Jurczak, Wojciech
BLOOD, 2021, 138
[38] Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: a population-based analysis
Di, Mengyang
Long, Jessica B.
Kothari, Shalin K.
Sethi, Tarsheen
Zeidan, Amer M.
Podoltsev, Nikolai A.
Shallis, Rory M.
Wang, Rong
Ma, Xiaome
Huntington, Scott F.
HAEMATOLOGICA, 2023, 108 (08) : 2218 - 2223
[39] The effect of Rituximab on patients with follicular and mantle-cell lymphoma
Ghielmini, M
Schmitz, SFH
Bürki, K
Pichert, G
Betticher, DC
Stupp, R
Wernli, M
Lohri, A
Schmitter, D
Bertoni, F
Cerny, T
ANNALS OF ONCOLOGY, 2000, 11 : 123 - 126
[40] Rituximab Maintenance Therapy after Autologous Stem Cell Transplantation Improves Survival of Patients with Mantle Cell Lymphoma
Graf, Solomon A.
Stevenson, Philip A.
Holmberg, Leona A.
Till, Brian G.
Press, Oliver W.
Chauncey, Thomas R.
Smith, Stephen D.
Philip, Mary
Orozco, Johnnie J.
Shustov, Andrei R.
Green, Damian J.
Libby, Edward N.
Bensinger, William I.
Pagel, John M.
Maloney, David G.
Zhou, Yi
Cassaday, Ryan D.
Gopal, Ajay K.
BLOOD, 2014, 124 (21)

← 1 2 3 4 5 →